MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617066803 A) filed by Mink Therapeutics, Inc. on May 27, 2026, for Allogeneic Invariant Natural Killer T Cells Adjuvant For Treatment Of Disease And Related Methods.
Inventor includes Purbhoo, Marco.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present disclosure relates to compositions comprising allogeneic invariant natural killer T (iNKT) cells, including allogeneic iNKT cell adjuvants, and methods of using the compositions comprising the iNKT cells for treatment of diseases and conditions, including cancer.
Disclaimer: Curated by HT Syndication.
